Suppr超能文献

对K位点I类错配骨髓移植的同种异体抗性完全由CD4 +和CD8 + T细胞介导。

Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.

作者信息

Hayashi H, LeGuern C, Sachs D H, Sykes M

机构信息

Transplantation Biology Research Center, Massachusetts General Hospital, Boston 002129, USA.

出版信息

Bone Marrow Transplant. 1996 Aug;18(2):285-92.

PMID:8864436
Abstract

Clinical application of approaches to inducing transplantation tolerance that involve bone marrow reconstitution will require achievement of engraftment without major toxicity to the recipient. These requirements are likely to vary according to the type of histoincompatibility between donor and recipient. We have attempted to determine the minimal conditioning required to achieve lasting mixed allogeneic chimerism and tolerance in the presence of a class I MHC disparity by evaluating the host elements that resist alloengraftment. We based our approach on a regimen that was shown to induce mixed chimerism in fully MHC-mismatched strain combinations. Recipient B10.AKM (KkIkDq) mice were treated with 7 Gy thymic irradiation (TI) and 3 Gy whole body irradiation (WBI) and received either anti-CD8 mAb alone or anti-CD4 plus anti-CD8 mAbs before transplantation of K locus-disparate B10.MBR (KbIkDq) marrow. All (27 of 27) animals receiving both mAbs showed lasting multi-lineage mixed chimerism and donor-specific tolerance. In contrast, five of 22 (23%) recipients pre-treated with anti-CD8 mAb alone in the same experiments failed to develop lasting multilineage mixed chimerism, suggesting that the CD4 T cell subset also participates in resistance to class I-mismatched marrow engraftment. We next attempted to determine whether or not host non-T cell elements resist allogeneic engraftment by comparing the minimum number of syngeneic vs allogeneic BMC required to achieve lasting multilineage mixed chimerism. Titrated numbers (10(6) to 10(7)) of B10.MBR (KbIkDq) bone marrow cells were administered to B10.AKM recipients treated with anti-CD4 and -CD8 mAbs, 3 Gy WBI and 7 Gy TI. All recipients of each marrow dose developed lasting multilineage mixed chimerism and showed specific tolerance to B10.MBR skin grafts. The level of donor-type repopulation in recipients of each dose was not lower than that observed in similarly irradiated recipients in an Ly5 congenic, otherwise syngeneic, BMT system. Together, our results suggest that CD4+ T cells contribute to resistance to K locus class I-mismatched marrow allografts and that resistance is mediated only by CD4 and CD8 T cells, with no role for non-T cell host elements.

摘要

涉及骨髓重建的诱导移植耐受方法的临床应用,将需要在不对受体产生重大毒性的情况下实现植入。这些要求可能会因供体和受体之间组织相容性的类型而异。我们试图通过评估抵抗同种异体植入的宿主因素,来确定在存在I类MHC差异的情况下实现持久混合同种异体嵌合和耐受所需的最小预处理。我们的方法基于一种已被证明能在完全MHC不匹配的品系组合中诱导混合嵌合的方案。受体B10.AKM(KkIkDq)小鼠接受7 Gy胸腺照射(TI)和3 Gy全身照射(WBI),并在移植K位点不同的B10.MBR(KbIkDq)骨髓之前单独接受抗CD8单克隆抗体或抗CD4加抗CD8单克隆抗体。所有(27只中的27只)接受两种单克隆抗体的动物都表现出持久的多谱系混合嵌合和供体特异性耐受。相比之下,在相同实验中单独用抗CD8单克隆抗体预处理的22只受体中有5只(23%)未能产生持久的多谱系混合嵌合,这表明CD4 T细胞亚群也参与了对I类不匹配骨髓植入的抵抗。接下来,我们试图通过比较实现持久多谱系混合嵌合所需的同基因与同种异体骨髓细胞的最小数量,来确定宿主非T细胞成分是否抵抗同种异体植入。将滴定数量(10^6至10^7)的B10.MBR(KbIkDq)骨髓细胞给予接受抗CD4和抗CD8单克隆抗体、3 Gy WBI和7 Gy TI治疗的B10.AKM受体。每个骨髓剂量的所有受体都产生了持久的多谱系混合嵌合,并对B10.MBR皮肤移植表现出特异性耐受。每个剂量受体中的供体型再增殖水平不低于在Ly5同基因、否则为同基因的BMT系统中类似照射受体中观察到的水平。总之,我们的结果表明CD4 + T细胞有助于抵抗K位点I类不匹配的骨髓同种异体移植,并且这种抵抗仅由CD4和CD8 T细胞介导,非T细胞宿主成分不起作用。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验